Purification and initiation of structural characterization of human peripheral myelin protein 22, an integral membrane protein linked to peripheral neuropathies

Biochemistry

Volumn 46, Issue 39, 2007, Pages 11185-11195

  Mobley, Charles K ^a   Myers, Jeffrey K ^a   Hadziselimovic, Arina ^a   Ellis, Charles D ^a   Sanders, Charles R ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; ENZYME ACTIVITY; ESCHERICHIA COLI; GENE EXPRESSION; HYDROPHOBICITY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

DISEASE LINKED MUTANTS; FUSION PROTEINS; HYDROPHOBIC PUTATIVE TETRASPAN INTEGRAL MEMBRANE PROTEINS; LAMBDA REPRESSORS; NEUROPATHIES;

PROTEINS;

DETERGENT; HISTIDINE; HYBRID PROTEIN; PERIPHERAL MYELIN PROTEIN 22; PROTEINASE;

AMINO ACID SEQUENCE; ARTICLE; CIRCULAR DICHROISM; CROSS LINKING; CRYSTALLOGRAPHY; DIMERIZATION; ESCHERICHIA COLI; HUMAN; HYDROPHOBICITY; MICELLE; NITROGEN NUCLEAR MAGNETIC RESONANCE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUCLEOTIDE SEQUENCE; PERIPHERAL NEUROPATHY; POTYVIRUS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN PURIFICATION; PROTON NUCLEAR MAGNETIC RESONANCE; SIGNAL DETECTION; STRUCTURE ANALYSIS; TOBACCO VIRUS;

AMINO ACID SEQUENCE; CIRCULAR DICHROISM; DIMERIZATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; MYELIN PROTEINS; PERIPHERAL NERVOUS SYSTEM DISEASES; PROTEIN STRUCTURE, TERTIARY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

ESCHERICHIA COLI; TOBACCO ETCH VIRUS;

EID: 34848892779     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi700855j     Document Type: Article

References (101)

1. Naef, R., and Suter, U. (1998) Many facets of the peripheral myelin protein PMP22 in myelination and disease, Microsc. Res. Tech. 41, 359-371.
2. Snipes, G. J., Suter, U., Welcher, A. A., and Shooter, E. M. (1992) Characterization of a novel peripheral nervous system myelin protein (PMP-22/SR13), J. Cell Biol. 117, 225-238.
3. D'Urso, D., and Muller, H. W. (1997) Ins and outs of peripheral myelin protein-22: mapping transmembrane topology and intra-cellular sorting, J. Neurosci. Res. 49, 551-562.
4. Sanders, C. R., Ismail-Beigi, F., and McEnery, M. W. (2001) Mutations of peripheral myelin protein 22 result in defective trafficking through mechanisms which may be common to diseases involving tetraspan membrane proteins, Biochemistry 40, 9453-9459.
5. Van Itallie, C. M., and Anderson, J. M. (2006) Claudins and epithelial paracellular transport, Annu. Rev. Physiol. 68, 403-429.
6. Taylor, V., Zgraggen, C., Naef, R., and Suter, U. (2000) Membrane topology of peripheral myelin protein 22, J. Neurosci. Res. 62, 15-27.
7. Jetten, A. M., and Suter, U. (2000) The peripheral myelin protein 22 and epithelial membrane protein family, Prog. Nucleic Acid Res. Mol. Biol. 64, 97-129.
8. Ohsawa, Y., Murakami, T., Miyazaki, Y., Shirabe, T., and Sunada, Y. (2006) Peripheral myelin protein 22 is expressed in human central nervous system, J. Neurol. Sci. 247, 11-15.
9. Suter, U., Snipes, G. J., Schoener-Scott, R., Welcher, A. A., Pareek, S., Lupski, J. R., Murphy, R. A., Shooter, E. M., and Patel, P. I. (1994) Regulation of tissue-specific expression of alternative peripheral myelin protein-22 (PMP22) gene transcripts by two promoters, J. Biol. Chem. 269, 25795-25808.
10. Adlkofer, K., Martini, R., Aguzzi, A., Zielasek, J., Toyka, K. V., and Suter, U. (1995) Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice, Nat. Genet. 11, 274-280.
11. Bronstein, J. M. (2000) Function of tetraspan proteins in the myelin sheath, Curr. Opin. Neurobiol. 10, 552-557.
12. Carenini, S., Neuberg, D., Schachner, M., Suter, U., and Martini, R. (1999) Localization and functional roles of PMP22 in peripheral nerves of P0-deficient mice, Glia 28, 256-264.
13. Quarles, R. H. (2002) Myelin sheaths: glycoproteins involved in their formation, maintenance and degeneration, Cell. Mol. Life Sci. 59, 1851-1871.
14. Amici, S. A., Dunn, W. A., Jr., and Notterpek, L. (2007) Developmental abnormalities in the nerves of peripheral myelin protein 22-deficient mice, J. Neurosci. Res. 85, 238-249.
15. Arroyo, E. J., and Scherer, S. S. (2000) On the molecular architecture of myelinated fibers, Histochem. Cell Biol. 113, 1-18.
16. Scherer, S. S., and Arroyo, E. J. (2002) Recent progress on the molecular organization of myelinated axons, J. Peripher. Nerv. Syst. 7, 1-12.
17. Shy, M. E. (2006) Peripheral neuropathies caused by mutations in the myelin protein zero, J. Neurol. Sci. 242, 55-66.
18. D'Urso, D., Ehrhardt, P., and Muller, H. W. (1999) Peripheral myelin protein 22 and protein zero: a novel association in peripheral nervous system myelin, J. Neurosci. 19, 3396-3403.
19. Hasse, B., Bosse, F., Hanenberg, H., and Muller, H. W. (2004) Peripheral myelin protein 22 kDa and protein zero: domain specific trans-interactions, Mol. Cell Neurosci. 27, 370-378.
20. Shapiro, L., Doyle, J. P., Hensley, P., Colman, D. R., and Hendrickson, W. A. (1996) Crystal structure of the extracellular domain from P-0, the major structural protein of peripheral nerve myelin, Neuron 17, 435-449.
21. Zoidl, G., Blass-Kampmann, S., D'Urso, D., Schmalenbach, C., and Müller, H. W. (1995) Retroviral-mediated gene transfer of the peripheral myelin protein PMP22 in Schwann cells: modulation of cell growth, EMBO J. 14, 1122-1128.
22. Roux, K. J., Amici, S. A., Fletcher, B. S., and Notterpek, L. (2005) Modulation of epithelial morphology, monolayer permeability, and cell migration by growth arrest specific 3/peripheral myelin protein 22, Mol. Biol. Cell 16, 1142-1151.
23. Atanasoski, S., Scherer, S. S., Nave, K. A., and Suter, U. (2002) Proliferation of Schwann cells and regulation of cyclin D1 expression in an animal model of Charcot-Marie-Tooth disease type 1A, J. Neurosci. Res. 67, 443-449.
24. Giambonini-Brugnoli, G., Buchstaller, J., Sommer, L., Suter, U., and Mantei, N. (2005) Distinct disease mechanisms in peripheral neuropathies due to altered peripheral myelin protein 22 gene dosage or a Pmp22 point mutation, Neurobiol. Dis. 18, 656-668.
25. Notterpek, L., Snipes, G. J., and Shooter, E. M. (1999) Temporal expression pattern of peripheral myelin protein 22 during in vivo and in vitro myelination, Glia 25, 358-369.
26. Notterpek, L., Roux, K. J., Amici, S. A., Yazdanpour, A., Rahner, C, and Fletcher, B. S. (2001) Peripheral myelin protein 22 is a constituent of intercellular junctions in epithelia, Proc. Natl. Acad. Sci. U.S.A. 98, 14404-14409.
27. Amici, S. A., Dunn, W. A., Jr., Murphy, A. J., Adams, N. C., Gale, N. W., Valenzuela, D. M., Yancopoulos, G. D., and Notterpek, L. (2006) Peripheral myelin protein 22 is in complex with alpha6beta4 integrin, and its absence alters the Schwann cell basal lamina, J. Neurosci. 26, 1179-1189.
28. Nicoll, R. A., Tomita, S., and Bredt, D. S. (2006) Auxiliary subunits assist AMPA-type glutamate receptors, Science 311, 1253-1256.
29. Ziff, E. B. (2007) TARPs and the AMPA receptor trafficking paradox, Neuron 53, 627-633.
30. Hua, V. B., Chang, A. B., Tchieu, J. H., Kumar, N. M., Nielsen, P. A., and Saier, M. H., Jr. (2003) Sequence and phylogenetic analyses of 4 TMS junctional proteins of animals: connexins, innexins, claudins and occludins, J. Membr. Biol. 194, 59-76.
31. Takeda, Y., Notsu, T., Kitamura, K., and Uyemura, K. (2001) Functional analysis for peripheral myelin protein PASII/PMP22: is it a member of claudin superfamily?, Neurochem. Res. 26, 599-607.
32. Evans, W. H., De, V. E., and Leybaert, L. (2006) The gap junction cellular internet: connexin hemichannels enter the signalling limelight, Biochem. J. 397, 1-14.
33. Koval, M. (2006) Pathways and control of connexin oligomerization, Trends Cell Biol. 16, 159-166.
34. Sosinsky, G. E., and Nicholson, B. J. (2005) Structural organization of gap junction channels, Biochim. Biophys. Acta 1711, 99-125.
35. Berger, P., Niemann, A., and Suter, U. (2006) Schwann cells and the pathogenesis of inherited motor and sensory neuropathies (Charcot-Marie-Tooth disease), Glia 54, 243-257.
36. Suter, U., and Scherer, S. S. (2003) Disease mechanisms in inherited neuropathies, Nat. Rev. Neurosci. 4, 714-726.
37. Saifi, G. M., Szigeti, K., Snipes, G. J., Garcia, C. A., and Lupski, J. R. (2003) Molecular mechanisms, diagnosis, and rational approaches to management of and therapy for Charcot-Marie-Tooth disease and related peripheral neuropathies, J. Invest. Med. 51, 261-283.
38. Colby, J., Nicholson, R., Dickson, K. M., Orfali, W., Naef, R., Suter, U., and Snipes, G. J. (2000) PMP22 carrying the trembler or trembler-J mutation is intracellularly retained in myelinating Schwann cells, Neurobiol. Dis. 7, 561-573.
39. D'Urso, D., Prior, R., Greiner-Petter, R., Gabreels-Festen, A. A., and Muller, H. W. (1998) Overloaded endoplasmic reticulum-Golgi compartments, a possible pathomechanism of peripheral neuropathies caused by mutations of the peripheral myelin protein PMP22, J. Neurosci. 18, 731-740.
40. Fortun, J., Dunn, W. A., Jr., Joy, S., Li, J., and Notterpek, L. (2003) Emerging role for autophagy in the removal of aggresomes in Schwann cells, J. Neurosci. 23, 10672-10680.
41. Fortun, J., Li, J., Go, J., Fenstermaker, A., Fletcher, B. S., and Notterpek, L. (2005) Impaired proteasome activity and accumulation of ubiquitinated substrates in a hereditary neuropathy model, J. Neurochem. 92, 1531-1541.
42. Naef, R., and Suter, U. (1999) Impaired intracellular trafficking is a common disease mechanism of PMP22 point mutations in peripheral neuropathies, Neurobiol. Dis. 6, 1-14.
43. Notterpek, L., Ryan, M. C., Tobler, A. R., and Shooter, E. M. (1999) PMP22 accumulation in aggresomes: implications for CMT1A pathology, Neurobiol. Dis. 6, 450-460.
44. Ryan, M. C., Shooter, E. M., and Notterpek, L. (2002) Aggresome formation in neuropathy models based on peripheral myelin protein 22 mutations, Neurobiol. Dis. 10, 109-118.
45. Tobler, A. R., Liu, N., Mueller, L., and Shooter, E. M. (2002) Differential aggregation of the Trembler and Trembler J mutants of peripheral myelin protein 22, Proc. Natl. Acad. Sci. U.S.A. 99, 483-488.
46. Liu, N., Yamauchi, J., and Shooter, E. M. (2004) Recessive, but not dominant, mutations in peripheral myelin protein 22 gene show unique patterns of aggregation and intracellular trafficking, Neurobiol. Dis. 17, 300-309.
47. Robaglia-Schlupp, A., Pizant, J., Norreel, J. C., Passage, E., Saberan-Djoneidi, D., Ansaldi, J. L., Vinay, L., Figarella-Branger, D., Levy, N., Clarac, F., Cau, P., Pellissier, J. F., and Fontes, M. (2002) PMP22 overexpression causes dysmyelination in mice, Brain 125, 2213-2221.
48. Huxley, C., Passage, E., Robertson, A. M., Youl, B., Huston, S., Manson, A., Saberan-Djoniedi, D., Figarella-Branger, D., Pellissier, J. F., Thomas, P. K., and Fontes, M. (1998) Correlation between varying levels of PMP22 expression and the degree of demyelination and reduction in nerve conduction velocity in transgenic mice, Hum. Mol. Genet. 7, 449-458.
49. Sereda, M. W., and Nave, K. A. (2006) Animal models of Charcot-Marie-Tooth disease type 1A, Neuromol. Med. 8, 205-216.
50. Fortun, J., Go, J. C, Li, J., Amici, S. A., Dunn, W. A., Jr., and Notterpek, L. (2006) Alterations in degradative pathways and protein aggregation in a neuropathy model based on PMP22 overexpression, Neurobiol. Dis. 22, 153-164.
51. Pareek, S., Notterpek, L., Snipes, G. J., Naef, R., Sossin, W., Labberte, J., Iacampo, S., Suter, U., Shooter, E. M., and Murphy, R. A. (1997) Neurons promote the translocation of peripheral myelin protein 22 into myelin, J. Neurosci. 17, 7754-7762.
52. Kitamura, K., Suzuki, M., and Uyemura, K. (1976) Purification and partial characterization of two glycoproteins in bovine peripheral nerve myelin membrane, Biochim. Biophys. Acta 455, 806-816.
53. Sedzik, J., Kotake, Y., and Uyemura, K. (1998) Purification of PASII/PMP22 - an extremely hydrophobic glycoprotein of PNS myelin membrane, Neuroreport 9, 1595-1600.
54. Sedzik, J., Uyemura, K., and Tsukihara, T. (2002) Towards crystallization of hydrophobic myelin glycoproteins: P0 and PASII/PMP22, Protein Expression Purif. 26, 368-377.
55. Kapust, R. B., Tozser, J., Fox, J. D., Anderson, D. E., Cherry, S., Copeland, T. D., and Waugh, D. S. (2001) Tobacco etch virus protease: mechanism of autolysis and rational design of stable mutants with wild-type catalytic proficiency, Protein Eng. 14, 993-1000.
56. Schmidt, T. G., and Skerra, A. (1994) One-step affinity purification of bacterially produced proteins by means of the "Strep tag" and immobilized recombinant core streptavidin, J. Chromatogr. A 676, 337-345.
57. Anumanthan, G., Haider, S. K., Friedman, D. B., and Datta, P. K. (2006) Oncogenic serine-threonine kinase receptor-associated protein modulates the function of Ewing sarcoma protein through a novel mechanism, Cancer Res. 66, 10824-10832.
58. Bender, R. P., Ham, A. J., and Osheroff, N. (2007) Quinone-induced enhancement of DNA cleavage by human topoisomerase IIalpha: adduction of cysteine residues 392 and 405, Biochemistry 46, 2856-2864.
59. Weigelt, J., Miles, C. S., Dixon, N. E., and Otting, G. (1998) Backbone NMR assignments and secondary structure of the N-terminal domain of DnaB helicase from E. coli, J. Biomol. NMR 11, 233-234.
60. Salzmann, M., Pervushin, K., Wider, G., Senn, H., and Wuthrich, K. (1999) [13C]-constant-time [15N,1H]-TROSY-HNCA for sequential assignments of large proteins, J. Biomol. NMR 14, 85-88.
61. Delaglio, F., Grzesiek, S., Vuister, G. W., Zhu, G., Pfeifer, J., and Bax, A. (1995) NMRPipe: a multidimensional spectral processing system based on UNIX pipes, J. Biomol. NMR 6, 277-293.
62. Ritz, M. F., Lechner-Scott, J., Scott, R. J., Fuhr, P., Malik, N., Erne, B., Taylor, V., Suter, U., Schaeren-Wiemers, N., and Steck, A. J. (2000) Characterisation of autoantibodies to peripheral myelin protein 22 in patients with hereditary and acquired neuropathies, J. Neuroimmunol. 104, 155-163.
63. Breyer, R. M., Ma, L., and Kennedy, C. (2002) Methods and compositions for high yield production of eukaryotic proteins, U.S. Patent 6,383,777.
64. Ryan, M. C., Notterpek, L., Tobler, A. R., Liu, N., and Shooter, E. M. (2000) Role of the peripheral myelin protein 22 N-linked glycan in oligomer stability, J. Neurochem. 75, 1465-1474.
65. Tobler, A. R., Notterpek, L., Naef, R., Taylor, V., Suter, U., and Shooter, E. M. (1999) Transport of Trembler-J mutant peripheral myelin protein 22 is blocked in the intermediate compartment and affects the transport of the wild-type protein by direct interaction, J. Neurosci. 19, 2027-2036.
66. Tobler, A. R., Liu, N., Mueller, L., and Shooter, E. M. (2002) Differential aggregation of the Trembler and Trembler J mutants of peripheral myelin protein 22, Proc. Natl. Acad. Sci. U.S.A. 99, 483-488.
67. Andrade, M. A., Chacon, P., Merelo, J. J., and Moran, F. (1993) Evaluation of secondary structure of proteins from UV circular dichroism spectra using an unsupervised learning neural network, Protein Eng. 6, 383-390.
68. Wu, C. S., Ikeda, K., and Yang, J. T. (1981) Ordered conformation of polypeptides and proteins in acidic dodecyl sulfate solution, Biochemistry 20, 566-570.
69. Batenjany, M. M., Mizukami, H., and Salhany, J. M. (1993) Near-UV circular dichroism of band 3. Evidence for intradomain conformational changes and interdomain interactions, Biochemistry 32, 663-668.
70. Brouillette, C. G., McMichens, R. B., Stern, L. J., and Khorana, H. G. (1989) Structure and thermal stability of monomeric bacteriorhodopsin in mixed phospholipid/detergent micelles, Proteins 5, 38-46.
71. Taylor, R. M., Zakharov, S. D., Bernard, H. J., Girvin, M. E., and Cramer, W. A. (2000) Folded state of the integral membrane colicin E1 immunity protein in solvents of mixed polarity, Biochemistry 39, 12131-12139.
72. Turk, E., Gasymov, O. K., Lanza, S., Horwitz, J., and Wright, E. M. (2006) A reinvestigation of the secondary structure of functionally active vSGLT, the vibrio sodium/galactose cotransporter, Biochemistry 45, 1470-1479.
73. Woody, R. W., and Dunker, A. K. (1996) Aromatic and cystine side-chain circular dichroism in proteins, in Circular dichroism and the conformational analysis of biomolecules (Fasman, G. D., Ed.) pp 109-157, Plenum Press, New York.
74. Kelly, S. M., and Price, N. C. (2000) The use of circular dichroism in the investigation of protein structure and function, 1st ed., pp 349-284.
75. Chill, J. H., Louis, J. M., Miller, C., and Bax, A. (2006) NMR study of the tetrameric KcsA potassium channel in detergent micelles, Protein Sci. 15, 684-698.
76. Koglin, A., Klammt, C., Trbovic, N., Schwarz, D., Schneider, B., Schafer, B., Lohr, F., Bernhard, F., and Dotsch, V. (2006) Combination of cell-free expression and NMR spectroscopy as a new approach for structural investigation of membrane proteins, Magn Reson. Chem. 44 Spec No., S17-S23.
77. Tamm, L. K., and Liang, B. Y. (2006) NMR of membrane proteins in solution, Prog. Nucl. Magn. Reson. Spectrosc. 48, 201-210.
78. Trbovic, N., Klammt, C., Koglin, A., Lohr, F., Bernhard, F., and Dotsch, V. (2005) Efficient strategy for the rapid backbone assignment of membrane proteins, J. Am. Chem. Soc. 127, 13504-13505.
79. Oxenoid, K., Kim, H. J., Jacob, J., Sonnichsen, F. D., and Sanders, C. R. (2004) NMR assignments for a helical 40 kDa membrane protein, J. Am. Chem. Soc. 126, 5048-5049.
80. Columbus, L., Lipfert, J., Klock, H., Millett, I., Doniach, S., and Lesley, S. A. (2006) Expression, purification, and characterization of Thermotoga maritima membrane proteins for structure determination, Protein Sci. 15, 961-975.
81. Page, R. C., Moore, J. D., Nguyen, H. B., Sharma, M., Chase, R., Gao, F. P., Mobley, C. K., Sanders, C. R., Ma, L., Sonnichsen, F. D., Lee, S., Howell, S. C., Opella, S. J., and Cross, T. A. (2006) Comprehensive evaluation of solution nuclear magnetic resonance spectroscopy sample preparation for helical integral membrane proteins, J. Struct. Funct. Genomics 7, 51-64.
82. Poget, S. F., Cahill, S. M., and Girvin, M. E. (2007) Isotropic bicelles stabilize the functional form of a small multidrug-resistance pump for NMR structural studies, J. Am. Chem. Soc. 129, 2432-2433.
83. Takeuchi, K., Takahashi, H., Kawano, S., and Shimada, I. (2007) Identification and characterization of the slowly exchanging pH-dependent conformational rearrangement in KcsA, J. Biol. Chem. 282, 15179-15186.
84. White, S. H. (2005) Membrane proteins of known 3-D structure.
85. Ruddock, L. W., and Molinari, M. (2006) N-glycan processing in ER quality control, J. Cell Sci. 119, 4373-4380.
86. Ellgaard, L., and Helenius, A. (2003) Quality control in the endoplasmic reticulum, Nat. Rev. Mol. Cell Biol. 4, 181-191.
87. Helenius, A., and Aebi, M. (2004) Roles of N-linked glycans in the endoplasmic reticulum, Annu. Rev. Biochem. 73, 1019-1049.
88. Dickson, K. M., Bergeron, J. J., Shames, I., Colby, J., Nguyen, D. T., Chevet, E., Thomas, D. Y., and Snipes, G. J. (2002) Association of calnexin with mutant peripheral myelin protein-22 ex vivo: a basis for "gain-of- function" ER diseases, Proc. Natl. Acad. Sci. U.S.A. 99, 9852-9857.
89. Fontanini, A., Chies, R., Snapp, E. L., Ferrarini, M., Fabrizi, G. M., and Brancolini, C. (2005) Glycan-independent role of calnexin in the intracellular retention of Charcot-Marie-tooth 1A Gas3/ PMP22 mutants, J. Biol. Chem. 280, 2378-2387.
90. Yamada, K., Sato, J., Oku, H., and Katakai, R. (2003) Conformation of the transmembrane domains in peripheral myelin protein 22. Part 1. Solution-phase synthesis and circular dichroism study of protected 17-residue partial peptides in the first putative transmembrane domain, J. Pept. Res. 62, 78-87.
91. Sanders, C. R., and Myers, J. K. (2004) Disease-related misassembly of membrane proteins, Annu. Rev. Biophys. Biomol. Struct. 33, 25-51.
92. Lorch, M., and Booth, P. J. (2004) Insertion kinetics of a denatured alpha helical membrane protein into phospholipid bilayer vesicles, J. Mol. Biol. 344, 1109-1121.
93. Mi, D., Kim, H. J., Hadziselimovic, A., and Sanders, C. R. (2006) Irreversible misfolding of diacylglycerol kinase is independent of aggregation and occurs prior to trimerization and membrane association, Biochemistry 45, 10072-10084.
94. Nagy, J. K., Lonzer, W. L., and Sanders, C. R. (2001) Kinetic study of folding and misfolding of diacylglycerol kinase in model membranes, Biochemistry 40, 8971-8980.
95. Nagy, J. K., and Sanders, C. R. (2004) Destabilizing mutations promote membrane protein misfolding, Biochemistry 43, 19-25.
96. Otzen, D. E. (2003) Folding of DsbB in mixed micelles: a kinetic analysis of the stability of a bacterial membrane protein, J. Mol. Biol. 330, 641-649.
97. Sehgal, P., and Otzen, D. E. (2006) Thermodynamics of unfolding of an integral membrane protein in mixed micelles, Protein Sci. 15, 890-899.
98. Tugarinov, V., Choy, W. Y., Orekhov, V. Y., and Kay, L. E. (2005) Solution NMR-derived global fold of a monomeric 82-kDa enzyme, Proc. Natl. Acad. Sci. U.S.A. 102, 622-627.
99. Malia, T. J., and Wagner, G. (2007) NMR structural investigation of the mitochondrial outer membrane protein VDAC and its interaction with antiapoptotic Bcl-xL, Biochemistry 46, 514-525.
100. Sanders, C. R., and Sonnichsen, F. (2006) Solution NMR of membrane proteins: practice and challenges, Magn Reson. Chem. 44 Spec No., S24-S40.
101. Stenson, P. D., Ball, E. V., Mort, M., Phillips, A. D., Shiel, J. A., Thomas, N. S., Abeysinghe, S., Krawczak, M., and Cooper, D. N. (2003) Human Gene Mutation Database (HGMD(R)): 2003 update, Hum. Mutat. 21, 577-581.